<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03643016</url>
  </required_header>
  <id_info>
    <org_study_id>2018-41</org_study_id>
    <nct_id>NCT03643016</nct_id>
  </id_info>
  <brief_title>Improving EPilepsy Surgery Management and progNOsis Using Virtual Epileptic Patient Software (VEP)</brief_title>
  <acronym>EPINOV</acronym>
  <official_title>Improving EPilepsy Surgery Management and progNOsis Using Virtual Epileptic Patient Software (VEP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Every year, thousands of patients worldwide with drug resistant focal epilepsy (DRE) undergo
      resective brain surgery with the aim of achieving seizure freedom.

      Despite technical advances over the last 50 years, the success rate of epilepsy surgery in
      terms of seizure freedom has not greatly improved, remaining overall at around 50%. Depending
      on features of individual cases, presurgical evaluation includes a first phase of
      non-invasive data including video-EEG recordings, magnetoencephalography, structural and
      functional neuroimaging and neuropsychological evaluation. If these investigations do not
      allow adequate localization of likely region of seizure organization in the brain (the
      epileptogenic zone, EZ), then a second invasive phase using intracerebral EEG recording may
      be necessary (stereoelectroencephalography, SEEG). Interpretation of SEEG remains difficult
      in many cases, in particular since seizure onset is often characterized by discharges that
      very rapidly involve several distinct brain regions.

      No reliable measuring instrument currently exists to combine the various prognostic factors
      for a given patient. This leads to great uncertainty on an individual scale in predicting the
      effects of surgery. The mapping of epileptic networks in patients with DRE is an innovative
      scientifically-validated and clinically-tested method to significantly improve accuracy of
      SEEG and presurgical interpretation and guide surgical strategies in patients with DRE.
      Therefore, we developed the Virtual Epilepsy Patient software. Retrospective study already
      demonstrated the pertinence of this approach in improving the anatomical mapping of
      epileptogenic networks. Now, we aim to prospectively demonstrate the role of VEP during
      presurgical evaluation of DRE patients
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical success, defined as seizure free patient without disabling side effect (clinical judgment) at 12-month follow-up</measure>
    <time_frame>12 months</time_frame>
    <description>Number of seizure (Engel I)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">356</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Group with Virtual Epileptic Patient brain access data</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group without Virtual Epileptic Patient brain access data</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Surgical strategy based on a software</intervention_name>
    <description>Surgical strategy décision based on a software</description>
    <arm_group_label>Group with Virtual Epileptic Patient brain access data</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient or pediatric patient suffering from drug-resistant focal epilepsy.

          -  Standardized presurgical evaluation including medical history, scalp video-EEG, 3T MRI
             (DTI and rsMRI), FDG-PET, Neuropsychological tests.

          -  Inpatient in one of the participating centers for recording seizure during long term
             SEEG-monitoring.

        Exclusion Criteria:

          -  Epilepsy surgery performed without the requirement of SEEG or contra-indication to
             epilepsy surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emilie Garrido-Pradalié</last_name>
    <role>Study Director</role>
    <affiliation>Assitance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabrice Bartolomei, MD/PhD</last_name>
    <phone>+33491385829</phone>
    <email>fabrice.bartolomei@ap-hm.fr</email>
  </overall_contact>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 21, 2018</study_first_submitted>
  <study_first_submitted_qc>August 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2018</study_first_posted>
  <last_update_submitted>August 21, 2018</last_update_submitted>
  <last_update_submitted_qc>August 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

